Long-term effects of recombinant human erythropoietin in patients treated with continuous peritoneal dialysis: safety aspects.
Bárány
P
P
Department of Renal Medicine, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
Tranaeus
A
A
Bergström
J
J
D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy*; D004921:Erythropoietin / Q000009:adverse effects*; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006973:Hypertension / Q000209:etiology; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010538:Peritonitis / Q000209:etiology; D011994:Recombinant Proteins / Q000009:adverse effects
D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin